Center for Cancers and Blood Disorders

Recent papers from Center for Cancers and Blood Disorders

1. 2026 Update on Clinical Trials in β‐ThalassemiaAmerican Journal of Hematology · 2026
2. Pyruvate Kinase Activation in the Management of Thalassemia and Sickle Cell DiseaseHemoglobin · 2026
3. Abstract CT004: Safety of prolonged checkpoint inhibitor exposure in alveolar soft part sarcoma (ASPS) patientsCancer Research · 2026
4. A Second Factor VIIIa Mimetic for Hemophilia A.2026
5. Abstract 1798: Nicotinamide phosphoribosyltransferase (NAMPT) inhibitor-resistant rhabdomyosarcoma (RMS) models exhibit alterations in metabolic and genomic profilesCancer Research · 2026
6. Longitudinal Study of Comorbidities and Clinical Outcomes in Persons With Pancreatic Disease Using Electronic Health RecordsPancreas · 2026
7. Patient‐Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non‐Transfusion‐Dependent β‐Thalassemia Treated in the BEYOND TrialEuropean Journal Of Haematology · 2026
8. Phase I study of ART-123 in combination with FOLFOX + bevacizumab for patients with metastatic colorectal cancer.Journal of Clinical Oncology · 2026
9. Targeted Therapies in Non–Small Cell Lung CancerAmerican Journal of Clinical Oncology · 2025
10. Achieving clinically meaningful changes in haemoglobin levels in patients with non‐transfusion‐dependent β‐thalassaemia treated with luspatercept: A post hoc analysis of the phase 2 BEYOND trialBritish Journal of Haematology · 2025
11. Luspatercept versus mitapivat for non‐transfusion‐dependent β‐thalassemia: Dare to compare?HemaSphere · 2025
12. Lifetime Risk of Liver Disease in Patients With β‐Thalassemia: Data From the de‐LIGHT Retrospective Cohort StudyEuropean Journal Of Haematology · 2025
13. Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term resultsBlood Advances · 2025
14. ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia VeraActa Haematologica · 2025
15. Pediatric Advance Care Planning and Adolescent Preparedness and Quality of Life: An RCTPEDIATRICS · 2025
16. ‘Phenoconversion’ in adult patients with β‐thalassemiaAmerican Journal of Hematology · 2024
17. Structural and functional analysis of salivary intercalated duct cells reveals a secretory phenotypeThe Journal of Physiology · 2023
18. Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myelomaBritish Journal of Haematology · 2022
19. Culturally Adapted Motivational Interviewing for Pediatric Acute Lymphoblastic Leukemia Adherence: Feasibility and AcceptabilityClinical Practice in Pediatric Psychology · 2022
20. Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, placebo‐controlled study (IRON‐CLAD)American Journal of Hematology · 2021